Pfenex's IPO

Pfenex raised a round of funding on July 24, 2014. Investors include Public.

Pfenex is a clinical-stage biotechnology company developing and commercializing high value and difficult to manufacture proteins. Our initial focus is on biosimilar therapeutics and our lead product i…

Articles about Pfenex's IPO: